loadpatents
Patent applications and USPTO patent grants for Adelman; Steven J..The latest application filed is for "use of estrogen receptor alpha modulators for the treatment of multiple sclerosis".
Patent | Date |
---|---|
Use of 17.beta.-dihydroequilenin as an antioxidant Grant 7,022,688 - Adelman , et al. April 4, 2 | 2006-04-04 |
Use of estrogen receptor alpha modulators for the treatment of multiple sclerosis App 20040167112 - Elloso, M. Merle ;   et al. | 2004-08-26 |
Method of treating cardiovascular disease App 20040097538 - Azrolan, Neal I. ;   et al. | 2004-05-20 |
Method of treating cardiovascular disease Grant 6,670,355 - Azrolan , et al. December 30, 2 | 2003-12-30 |
Method of inhibiting cell death App 20030176455 - Adelman, Steven J. | 2003-09-18 |
Method of treating cardiovascular disease App 20030149070 - Azrolan, Neal I. ;   et al. | 2003-08-07 |
Methods for increasing nitric oxide synthase activity App 20020022617 - Adelman, Steven J. ;   et al. | 2002-02-21 |
Method of treating cardiovascular disease App 20020013335 - Azrolan, Neal I. ;   et al. | 2002-01-31 |
Anti-atherosclerotic use of 17 alpha-dihydroequilin Grant 5,482,935 - Adelman , et al. January 9, 1 | 1996-01-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.